Početna › Autoimune bolesti › Michigan
Kliničke studije za Autoimune bolesti u državi Michigan
9 studija za Autoimune bolesti traži sudionike na lokacijama u državi Michigan.
Gradovi u državi Michigan
Službeni tekst studije (engleski)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Clinical Research Inst of MI, Saint Clair Shores
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07621809Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- University of Michigan, Ann Arbor
U tijeku regrutacijaOpažajna studija
1 Month – 100 Years · Oba spola · Ažurirano 24. ruj 2026. · NCT00246857RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of Michigan - Accepting Young Adult and Juvenile Patients, Ann Arbor
U tijeku regrutacijaFaza 2/3
Od 6 do 75 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06154252Daratumumab in Primary Antiphospholipid Syndrome
- University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT05671757RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06328777A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06056297Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1026, Detroit
- Site Number - 1005, East Lansing
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Michigan, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- i još 2
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 6. srp 2026. · NCT01351545A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Karmanos Cancer Institute, Detroit
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT06626919Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.